SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-K


                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934


        Date of Report (date of earliest event reported): April 20, 2011


                           EFT BIOTECH HOLDINGS, INC.
                       -----------------------------------
             (Exact name of Registrant as specified in its charter)


     Nevada                            000-53730                   20-1211204
------------------------------   ---------------------     --------------------
(State or other jurisdiction     (Commission File No.)         (IRS Employer
of incorporation)                                           Identification No.)



                        17800 Castleton Street, Suite 300
                           City of Industry, CA 91748
                   -------------------------------------------
          (Address of principal executive offices, including Zip Code)


             Registrant's telephone number, including area code: (626) 581-3335
                                                                 --------------




                                       N/A
                    -----------------------------------------
          (Former name or former address if changed since last report)
<PAGE>


Item 5.02.  Departure of Directors or Certain  Officers;  Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

     On March 21, 2011  Jeffrey  Cheung  (age 51) was  appointed  the  Company's
Principal  Financial and Accounting  Officer.  Between 2001 and 2010, Mr. Cheung
was  the  CFO at  NetDimensions,  a U.K.  listed  company  engaged  in  software
development with focuses on learning and knowledge  management  technology.  Mr.
Cheung  is a  fellow  member  of  Certified  General  Accountants  (Canada)  and
Association of Chartered Certified  Accountants (`ACCA'). He is also a member of
the Hong Kong Institute of Taxation.  He began his career as an audit accountant
with Peat Marwick Mitchell & Co. in 1983. Mr. Cheung has served in various roles
with,  including  financial  controller  of Oracle  (HK)  Limited  and was a tax
auditor with Revenue  Canada.  Mr. Cheung holds a BA in accounting and financial
management  from the  University of Sheffield and an MBA from  Sheffield  Hallam
University.  Mr.  Cheung  served  on the  board of the Hong  Kong  branch of the
Association of Certified General Accountants (CGA-HK) from 2001 - 2007


     With the appointment of Mr. Cheung,  Jack Jie Qin resigned as the Company's
Principal  Financial and  Accounting  Officer.  Mr. Qin remains as the Company's
President, Chief Executive Officer and a Director.

<PAGE>

                                   SIGNATURES


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


Date:  April 20, 2011

                                 EFT BIOTECH HOLDINGS, INC.



                                 By:  /s/ Jack Jie Qin
                                      ----------------------------
                                      Jack Jie Qin, President
[{"type": "8-K", "sequence": "1", "filename": "form8kchueng502april-11.txt", "description": "APRIL 20, 2011 8-K ITEM 5.02", "secsgml_size_bytes": 3425}]
{"company-data": {"conformed-name": "EFT BIOTECH HOLDINGS INC", "cik": "0001450973", "assigned-sic": "5990", "irs-number": "770719310", "state-of-incorporation": "NV", "fiscal-year-end": "0331"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-53730", "film-number": "11773799"}, "business-address": {"street1": "929 RADECK CT", "city": "CITY OF INDUSTRY", "state": "CA", "zip": "91748", "phone": "626 581 0388"}, "mail-address": {"street1": "929 RADECK CT", "city": "CITY OF INDUSTRY", "state": "CA", "zip": "91748"}}
SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

        Date of Report (date of earliest event reported): April 20, 2011

                           EFT BIOTECH HOLDINGS, INC.
                       -----------------------------------
             (Exact name of Registrant as specified in its charter)

     Nevada                            000-53730                   20-1211204
------------------------------   ---------------------     --------------------
(State or other jurisdiction     (Commission File No.)         (IRS Employer
of incorporation)                                           Identification No.)

                        17800 Castleton Street, Suite 300
                           City of Industry, CA 91748
                   -------------------------------------------
          (Address of principal executive offices, including Zip Code)

             Registrant's telephone number, including area code: (626) 581-3335
                                                                 --------------

                                       N/A
                    -----------------------------------------
          (Former name or former address if changed since last report)
Item 5.02.  Departure of Directors or Certain  Officers;  Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

     On March 21, 2011  Jeffrey  Cheung  (age 51) was  appointed  the  Company's
Principal  Financial and Accounting  Officer.  Between 2001 and 2010, Mr. Cheung
was  the  CFO at  NetDimensions,  a U.K.  listed  company  engaged  in  software
development with focuses on learning and knowledge  management  technology.  Mr.
Cheung  is a  fellow  member  of  Certified  General  Accountants  (Canada)  and
Association of Chartered Certified  Accountants (`ACCA'). He is also a member of
the Hong Kong Institute of Taxation.  He began his career as an audit accountant
with Peat Marwick Mitchell & Co. in 1983. Mr. Cheung has served in various roles
with,  including  financial  controller  of Oracle  (HK)  Limited  and was a tax
auditor with Revenue  Canada.  Mr. Cheung holds a BA in accounting and financial
management  from the  University of Sheffield and an MBA from  Sheffield  Hallam
University.  Mr.  Cheung  served  on the  board of the Hong  Kong  branch of the
Association of Certified General Accountants (CGA-HK) from 2001 - 2007

     With the appointment of Mr. Cheung,  Jack Jie Qin resigned as the Company's
Principal  Financial and  Accounting  Officer.  Mr. Qin remains as the Company's
President, Chief Executive Officer and a Director.
SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date:  April 20, 2011

                                 EFT BIOTECH HOLDINGS, INC.

                                 By:  /s/ Jack Jie Qin
                                      ----------------------------
                                      Jack Jie Qin, President